Pricing Log in Create free account

Edesa Biotech, Inc. (EDSA) vs Quince Therapeutics, Inc. (IRLA)

Edesa Biotech, Inc. and Quince Therapeutics, Inc. are both Biotechnology companies. Edesa Biotech, Inc. and Quince Therapeutics, Inc. are of similar size ($36.1M and $33.8M). Across the 7 metrics below, Quince Therapeutics, Inc. leads on 5 and Edesa Biotech, Inc. on 2.

Valuation

Metric EDSA IRLA Biotechnology median
P/E n/m n/m 8.50
P/S 70.40 n/m 9.71
P/B 58.02 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 38.98 n/m 9.21
Earnings yield (65.76%) (442.37%) (33.15%)
Free cash flow yield (38.51%) (23.96%) (25.50%)

Profitability

Metric EDSA IRLA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (531.32%) 784.09% (56.36%)
Return on assets (102.46%) (76.68%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EDSA IRLA Biotechnology median
Revenue growth (TTM) (43.48%) — 6.02%
EPS growth (last fiscal year) 34.20% (28.24%) 30.26%
Revenue growth, 5-year CAGR (15.40%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EDSA IRLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.76 14.52 4.72
Net debt to EBITDA 1.39 0.00 0.96

Dividend

Metric EDSA IRLA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EDSA IRLA Biotechnology median
Market cap 36.08m 33.79m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack